Phoenix Wealth Advisors Exact Sciences Corp Transaction History

Phoenix Wealth Advisors

  • $215 Million
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024
SELL
$59.06 - $75.72 $6,673 - $8,556
-113 Reduced 1.97%
5,620 $415,000
Q3 2023

Nov 06, 2023
SELL
$65.94 - $99.04 $10,946 - $16,440
-166 Reduced 2.81%
5,733 $391,000
Q2 2023

Jul 13, 2023
SELL
$62.68 - $95.05 $18,804 - $28,515
-300 Reduced 4.84%
5,899 $553,000
Q1 2023

May 05, 2023
SELL
$47.19 - $70.77 $10,145 - $15,215
-215 Reduced 3.35%
6,199 $420,000
Q4 2022

Feb 06, 2023
SELL
$30.35 - $53.15 $28,377 - $49,695
-935 Reduced 12.72%
6,414 $317,000
Q3 2022

Nov 07, 2022
BUY
$31.97 - $49.37 $234,947 - $362,820
7,349 New
7,349 $239,000
Q2 2022

Aug 01, 2022
SELL
$35.61 - $76.23 $388,184 - $830,983
-10,901 Closed
0 $0
Q1 2022

May 02, 2022
BUY
$57.56 - $82.54 $83,001 - $119,022
1,442 Added 15.24%
10,901 $749,000
Q4 2021

Feb 11, 2022
BUY
$72.5 - $100.68 $242,367 - $336,573
3,343 Added 54.66%
9,459 $736,000
Q3 2021

Nov 15, 2021
BUY
$90.24 - $124.05 $8,211 - $11,288
91 Added 1.51%
6,116 $584,000
Q2 2021

Jul 23, 2021
BUY
$93.66 - $139.27 $8,710 - $12,952
93 Added 1.57%
6,025 $735,000
Q1 2021

Apr 12, 2021
BUY
$116.57 - $155.01 $170,891 - $227,244
1,466 Added 32.83%
5,932 $786,000
Q4 2020

Feb 05, 2021
BUY
$99.61 - $142.12 $444,858 - $634,707
4,466 New
4,466 $592,000

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Phoenix Wealth Advisors Portfolio

Follow Phoenix Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Phoenix Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Phoenix Wealth Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email